Home > Therapeutic area expertise > Pediatric clinical trials
Conducting clinical trials with children comes with unique challenges that highlight the value of every piece of data we collect. Only 20% of the US population is younger than 14 years of age, meaning that the pediatric population is limited and making recruitment particularly challenging, especially since children are much less likely than adults to suffer from serious illnesses.
The pediatric patient population is also very diverse, with preferences and habits varying significantly across age ranges. Transitioning between age groups during the trial can cause confusion in the attribution of questionnaires, and both the disease and the clinical trial can conflict with important aspects of a child’s life.
“We need to consider the patient journey over time, as young patients may become teenagers or young adults by the end of the trial. Biological changes, consent requirements, and evolving expectations must be analyzed to keep patients engaged.“
Begoña Nafria, Head of the Patient Engagement in Research Department at SJD Research Foundation
To address these challenges, we collaborate closely with sites, as they are directly engaged with the patient population and have a thorough understanding of the specificities of pediatric clinical trials. This collaboration is crucial for the meaningful integration of electronic Clinical Outcome Assessments (eCOA) and to improve data collection and analysis.
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona
Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20
Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA